Smiley, I totally believe that. Through my correspondence, BP seems like a great guy that isn't "wired" that way. I am sure that he never saw it coming. Lots of POS out there......
Wursthorn led me to believe it would be positive as well when he interviewed me. I asked him 3 times (separate) to interview Misiu, stating her knowledge, as a doctor was superior to most people on the history and clinical data on Leronlimab. He assured me he would interview her. I was very very disappointed
Did CytoDyn and Patterson in fact receive an email from OWS and decide not to proceed or just haven't done so yet? Will the WSJ be issuing a retraction?
In the proactive interview, Nader says he hasn't applied for BARDA funding, but in the WSJ article, Wursthorn wrote that CytoDyn has applied to BARDA and has been turned down, correct? Could it be that Wursthorn is seriously short the stock and working in collusion with other shorts?